H.R. 4813 (111th): To provide for insurance reform (including health insurance reform), amend title XVIII of the Social Security Act to reform Medicare Advantage and reduce disparities in the Medicare Program, regulate the importation of prescription drugs, and for other purposes.

Introduced:
Mar 10, 2010 (111th Congress, 2009–2010)
Status:
Died (Referred to Committee)
Sponsor
Robert “Marion” Berry
Representative for Arkansas's 1st congressional district
Party
Democrat
Text
Read Text »
Last Updated
Mar 10, 2010
Length
180 pages
 
Status

This bill was introduced on March 10, 2010, in a previous session of Congress, but was not enacted.

Progress
Introduced Mar 10, 2010
Referred to Committee Mar 10, 2010
 
Summary

No summaries available.

Cosponsors
2 cosponsors (1D, 1R) (show)
Committees

House Education and the Workforce

Health, Employment, Labor, and Pensions

House Energy and Commerce

House Oversight and Government Reform

House Judiciary

Courts, Intellectual Property, and the Internet

Immigration and Border Security

House Ways and Means

The committee chair determines whether a bill will move past the committee stage.

 
Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.

Widget

Get a bill status widget for your website »

Citation

Click a format for a citation suggestion:

Notes

H.R. stands for House of Representatives bill.

A bill must be passed by both the House and Senate in identical form and then be signed by the president to become law.

The bill’s title was written by its sponsor.

GovTrack’s Bill Summary

We don’t have a summary available yet.

Library of Congress Summary

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.


3/10/2010--Introduced.
Amends the McCarran-Ferguson Act to restore application of the Clayton Act and other antitrust laws to insurers.
Prohibits premium variation except by geographic premium rating area and by family enrollment.
Requires each health benefits plan issuer that offers health insurance coverage in the individual or group market in a state to accept every employer and individual in the state that applies for such coverage.
Places restrictions on federal funding of abortion, except in cases of certain physical conditions, rape, or incest.
Limits a health benefits plan to selling health insurance coverage to U.S. citizens and lawful resident aliens.
Amends title XVIII (Medicare) and title XIX (Medicaid) of the Social Security Act to revise requirements for: (1) Medicare Advantage, with respect to the blended benchmark amount and elimination of the MA Regional Plan Stabilization Fund; (2) an increase in the physician fee schedule practice expense geographic adjustment; (3) establishment of a Medicare operated prescription drug plan option; and (4) pharmacy reimbursement.
Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to revise requirements for the importation of prescription drugs. Requires the registration of importers and exporters.
Prescribes requirements for: (1) the disposition of certain drugs denied admission into the United States; (2) alternative identification of the chain of custody of certain prescription drugs, including through the use of standardized anti-counterfeiting or track-and-trace technologies; and (3) the sale of prescription drugs through an Internet site.
Prohibits the introduction of restricted transactions with unregistered foreign pharmacies into a payment system or the completion of such transactions using a payment system.
Amends the Internal Revenue Code to disallow a deduction from income for advertising and promotional expenses for prescription pharmaceuticals.
Requires a pharmacy benefit manager with a contract with a health benefits plan to comply with fiduciary standards established by the Secretary of Health and Human Services (HHS).
Amends SSA title XIX (Medicaid) to require any drug manufacturer with a rebate agreement concerning covered outpatient drugs to report to the HHS Secretary following a rebate period the total number of units used to calculate the monthly average manufacturer price for each covered outpatient drug.

House Republican Conference Summary

The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.


No summary available.

House Democratic Caucus Summary

The House Democratic Caucus does not provide summaries of bills.

So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.

We’ll be looking for a source of summaries from the other side in the meanwhile.

Use the comment space below for discussion of the merits of H.R. 4813 (111th) with other GovTrack users.
Your comments are not read by Congressional staff.

comments powered by Disqus